NAMSA
Go back
0.00
- Investment date: 2020
- Headquarter Location: United States
- Website: www.namsa.com
- Sector: MedTech
Founded in 1967 in the Unites States, NAMSA is the global industry leading Contract Research Organization (CRO) for preclinical and clinical medical device companies, and a global market leader in preclinical and biocompatibility testing. The company provides a comprehensive range of medical device CRO services such as testing, consulting, clinical services, and in vitro diagnostics.
Latest news
NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp
January 08, 2026
NAMSA Acquires WuXi AppTec US Medical Device Testing Operations
January 17, 2025
ARCHIMED completes seventh acquisition for NAMSA, the world leader in Medical Device testing services
March 27, 2023
ARCHIMED’s NAMSA returns more than a third of investment
October 07, 2021